Latka logo

Oxford Drug Design Revenue & Funding (2024)

Oxford Drug Design generated an estimated $2.7M in annual revenue in 2024. Source: GetLatka estimate

InhibOx is a pioneer in the development and application of new technologies to drive drug discovery. Their multidisciplinary research team has brought together breakthroughs in computational chemistry, cheminformatics, mathematics, cloud computing and software-as-a-service (SaaS) delivery methods to create DrugFinder: the next generation drug discovery platform.

Last updated

Oxford Drug Design Revenue

In 2024, Oxford Drug Design's revenue reached $2.7M. The company previously reported $1.4M in 2023. Since its launch in 2001, Oxford Drug Design has shown consistent revenue growth.

Oxford Drug Design Revenue GrowthReported revenue / ARR over time · latest figure estimated$0$600K$1.2M$1.8M$2.4M$3M2001200320052007200920112013201520172019202120232024$0$709.9K$2.7MSource: GetLatka.com
YearMilestoneSource
2024Oxford Drug Design Hit $2.7m revenue in October 2024Estimated
2023Oxford Drug Design Hit $1.4m revenue in November 2023Estimated
2022Oxford Drug Design Hit $1.1m revenue in May 2022Not recorded
2021Oxford Drug Design Hit $709.9k revenue in April 2021Not recorded
2001Launched with $0 revenue

Oxford Drug Design Valuation, Funding Rounds

Oxford Drug Design has not publicly disclosed its valuation. The company has raised $12.4M in total funding to date.

Oxford Drug Design has raised $12.4M in total funding across 5 rounds, most recently a $2.7M Convertible Note round in 2022.

Oxford Drug Design Capital Raised & ValuationCumulative capital raised and post-money valuation by roundCapital raised (cum.)Valuation$0$0$0.2$3M$0.4$6M$0.6$9M$0.8$12M$1$15M200120032005200720092011201320152017201920212022Source: GetLatka.com
YearRoundAmountValuation% SoldSource
2022Convertible Note$2.7M--Not recorded
2019Venture$2.7M--Not recorded
2019Grant$3.2M--Not recorded
2017Series A$1.2M--Not recorded
2006Venture$2.4M--Not recorded

Founder / CEO

Oxford Drug Design Employees & Team Size

Oxford Drug Design employs approximately 11 people as of 2026.

Oxford Drug Design Team GrowthReported headcount over time06121824302001200320052007200920112013201520172019202120232024001111Source: GetLatka.com
YearMilestoneSource
2024Reached 11 employees (October 2024)Not recorded
2023Reached 11 employees (November 2023)Not recorded
2022Reached 9 employees (November 2022)Not recorded
2022Reached 9 employees (May 2022)Not recorded
2021Reached 7 employees (November 2021)Not recorded
2021Reached 25 employees (April 2021)Not recorded
2020Reached 7 employees (November 2020)Not recorded

Frequently Asked Questions about Oxford Drug Design

What is Oxford Drug Design's revenue?

As of 2024, Oxford Drug Design generated an estimated $2.7M in annual revenue.

Who founded Oxford Drug Design?

Oxford Drug Design was founded by Graham Richards.

When was Oxford Drug Design founded?

Oxford Drug Design was founded in 2001.

Who is the CEO of Oxford Drug Design?

The CEO of Oxford Drug Design is Graham Richards.

How much funding does Oxford Drug Design have?

Oxford Drug Design raised $12.4M across 5 rounds.

How many employees does Oxford Drug Design have?

As of 2024, Oxford Drug Design had 11 employees.

Where is Oxford Drug Design headquartered?

Oxford Drug Design is headquartered in Oxford, United Kingdom.

Compare Oxford Drug Design to the industry

Oxford Drug Design operates across multiple industries. Browse revenue, funding, and growth data for Oxford Drug Design in each sector below.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile